| Added by | pmartino |
|---|---|
| Group name | EquipePM |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: IRCM, Institut de Recherche en Cancerologie de Montpellier, Montpellier, F-34298, France; INSERM, U1194, Montpellier, F-34298, France; Universite de Montpellier, Montpellier, F-34090, France; Institut regional du Cancer de Montpellier, Montpellier, F-34298, France. Centre Hospitalier Universitaire de Toulouse, F-31300, France; Centre de Recherche en Cancerologie de Toulouse, Unite Mixte de Recherche 1037 INSERM - Universite Toulouse III, France. Universite de Versailles, Boulogne, France; Hopital Ambroise Pare, Boulogne, France. Universite de Montpellier, Montpellier, F-34090, France; Service d'Anatomie et Cytologie Pathologiques, CHU Nimes, Place du Professeur Debre, 30029, Nimes, France. INSERM U916, Institut Bergonie, Universite de Bordeaux, France. Service d'oncologie medicale, CHU Dupuytren, avenue Luther-King, 87000, Limoges, France. IRCM, Institut de Recherche en Cancerologie de Montpellier, Montpellier, F-34298, France; INSERM, U1194, Montpellier, F-34298, France; Universite de Montpellier, Montpellier, F-34090, France; Institut regional du Cancer de Montpellier, Montpellier, F-34298, France. Electronic address: pierre.martineau@inserm.fr. alt-title: European journal of cancer accession-num: 28284171 |
| Tags | _EndnoteXML import |
| Date Added | 2020/07/13 - 09:05:52 |
| Date Modified | 2021/03/05 - 10:46:38 |
| Parent item | Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies |
Institut de Recherche en Cancérologie de
